These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3440938)

  • 1. Structure of phenylbutazone and mofebutazone in the crystalline state and in solution.
    Paradies HH
    J Pharm Sci; 1987 Dec; 76(12):920-9. PubMed ID: 3440938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-resolution solid-state carbon-13 nuclear magnetic resonance spectra of mofebutazone, phenylbutazone, and oxyphenbutazone in relation to X-ray crystallographic data.
    Stoltz M; Oliver DW; Wessels PL; Chalmers AA
    J Pharm Sci; 1991 Apr; 80(4):357-62. PubMed ID: 1865336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of mofebutazone in comparison to phenylbutazone on the adenosine triphosphate level of polymorphonuclear cells and their migration.
    Partsch G
    Arzneimittelforschung; 1992 Nov; 42(11):1336-8. PubMed ID: 1492846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacology, toxicology and pharmacokinetics of mofebutazone].
    Loew D; Schuster O; Knoell HE; Graul EH
    Z Rheumatol; 1985; 44(4):186-92. PubMed ID: 4050150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The interaction of mofebutazone with furosemide.
    Matthei U; Grabensee B; Loew D
    Curr Med Res Opin; 1987; 10(9):638-44. PubMed ID: 3481307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of [4-14C] mofebutazone after oral administration in man.
    Kassem MA; Schulte KE
    Eur J Drug Metab Pharmacokinet; 1984; 9(3):223-7. PubMed ID: 6519123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mofebutazone--evaluation of possible interaction with glibenclamide].
    Speders S
    Fortschr Med; 1993 Aug; 111(22-23):366-8. PubMed ID: 8406274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Distribution of 4-14C-mofebutazone in the rat].
    Loew D; Schuster O; Graul EH
    Z Rheumatol; 1986; 45(2):83-6. PubMed ID: 3727816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tolerability of mofebutazone in asthmatic patients.
    Khayyal MT; El-Ghazaly M; El-Khatib AS; Hatem A
    Int J Clin Pharmacol Res; 1995; 15(4):145-51. PubMed ID: 8871264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mofebutazone--mechanism of action, pharmacokinetics, tolerance].
    Fortschr Med Suppl; 1992; 123():3-13. PubMed ID: 1547984
    [No Abstract]   [Full Text] [Related]  

  • 11. Self-association of unconjugated bilirubin-IX alpha in aqueous solution at pH 10.0 and physical-chemical interactions with bile salt monomers and micelles.
    Carey MC; Koretsky AP
    Biochem J; 1979 Jun; 179(3):675-89. PubMed ID: 38779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Kinetics of mofebutazone in plasma and synovial fluid].
    Kamp J; Loew D; Barkow D; Deister J; Schuster O; Knoell HE
    Z Rheumatol; 1984; 43(4):179-81. PubMed ID: 6495891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of mofebutazone and its 4-hydroxy metabolite in plasma and urine by high-performance liquid chromatography.
    Delbeke FT; Debackere M
    J Chromatogr; 1986 Nov; 369(2):440-4. PubMed ID: 3805210
    [No Abstract]   [Full Text] [Related]  

  • 14. A method for determining transmembrane helix association and orientation in detergent micelles using small angle x-ray scattering.
    Bu Z; Engelman DM
    Biophys J; 1999 Aug; 77(2):1064-73. PubMed ID: 10423450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laser light scattering evidence for a common wormlike growth structure of mixed micelles in bile salt- and straight-chain detergent-phosphatidylcholine aqueous systems: relevance to the micellar structure of bile.
    Cohen DE; Thurston GM; Chamberlin RA; Benedek GB; Carey MC
    Biochemistry; 1998 Oct; 37(42):14798-814. PubMed ID: 9778354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural comparisons of the native and reactive-centre-cleaved forms of alpha 1-antitrypsin by neutron- and X-ray-scattering in solution.
    Smith KF; Harrison RA; Perkins SJ
    Biochem J; 1990 Apr; 267(1):203-12. PubMed ID: 2327980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delayed-type hypersensitivity to mofebutazone underlying a severe drug reaction.
    Walchner M; Rueff F; Przybilla B
    Contact Dermatitis; 1997 Jan; 36(1):54-5. PubMed ID: 9034692
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhibition of leukotriene release by mofebutazone: a possible clinical advantage.
    Khayyal MT; el-Khatib AS; el-Ghazaly M; Hatem A
    Int J Clin Pharmacol Res; 1993; 13(5):255-61. PubMed ID: 8200720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphism of phenylbutazone: properties and compressional behavior of crystals.
    Ibrahim HG; Pisano F; Bruno A
    J Pharm Sci; 1977 May; 66(5):669-73. PubMed ID: 874748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tunable parameters for the structural control of reverse micelles in glycerol monoisostearate/oil systems: a SAXS study.
    Shrestha LK; Shrestha RG; Varade D; Aramaki K
    Langmuir; 2009 Apr; 25(8):4435-42. PubMed ID: 19243155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.